Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice

Dinorah Friedmann-Morvinski1, Eric A Bushong, Eugene Ke

  • 1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Science (New York, N.Y.)
|October 23, 2012
PubMed

Insights

Malignant gliomas, including glioblastoma, can arise from mature brain cells like neurons. Genetic changes cause these cells to dedifferentiate into stem-like cells, driving tumor growth and diversity.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumor.
  • The cellular origin of GBM remains a critical question in neuro-oncology.

Purpose of the Study:

  • To investigate whether differentiated central nervous system (CNS) cells can initiate glioma formation.
  • To characterize the cellular state and molecular subtype of experimentally induced gliomas.

Main Methods:

  • Oncogenic lentiviral vectors were used to transduce neural stem cells (NSCs), astrocytes, and mature neurons in mouse brains.
  • Tumorigenesis was monitored, and resulting gliomas were analyzed for stem/progenitor and differentiation markers.
  • Microarray analysis was performed to determine molecular subtypes.

Main Results:

  • Gliomas were successfully induced from NSCs, astrocytes, and mature neurons.
  • All induced tumors exhibited high expression of stem/progenitor markers and low differentiation markers.
  • Tumors of astrocytic and neuronal origin were classified as the mesenchymal GBM subtype.

Conclusions:

  • Differentiated CNS cells, including neurons, can dedifferentiate into a neural stem cell or progenitor state to initiate malignant gliomas.
  • This dedifferentiation process is crucial for tumor initiation, progression, and the observed cellular heterogeneity in gliomas.
  • Findings suggest a novel mechanism for glioma development involving cellular plasticity in the adult CNS.